These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
457 related articles for article (PubMed ID: 9641886)
21. Current state of adjuvant therapy in resected pancreatic adenocarcinoma. Bergenfeldt M; Albertsson M Acta Oncol; 2006; 45(2):124-35. PubMed ID: 16546857 [TBL] [Abstract][Full Text] [Related]
22. A systematic overview of chemotherapy effects in colorectal cancer. Ragnhammar P; Hafström L; Nygren P; Glimelius B; Acta Oncol; 2001; 40(2-3):282-308. PubMed ID: 11441937 [TBL] [Abstract][Full Text] [Related]
23. Overall survival is increased among stage III pancreatic adenocarcinoma patients receiving neoadjuvant chemotherapy compared to surgery first and adjuvant chemotherapy: An intention to treat analysis of the National Cancer Database. Shubert CR; Bergquist JR; Groeschl RT; Habermann EB; Wilson PM; Truty MJ; Smoot RL; Kendrick ML; Nagorney DM; Farnell MB Surgery; 2016 Oct; 160(4):1080-1096. PubMed ID: 27522556 [TBL] [Abstract][Full Text] [Related]
24. Pancreatic adenocarcinoma: effects of neoadjuvant therapy on post-pancreatectomy outcomes - an American College of Surgeons National Surgical Quality Improvement Program targeted variable review. Czosnyka NM; Borgert AJ; Smith TJ HPB (Oxford); 2017 Oct; 19(10):927-932. PubMed ID: 28747265 [TBL] [Abstract][Full Text] [Related]
25. [Chemotherapy, combined radiochemotherapy and new therapeutic approaches in adenocarcinoma of the pancreas]. André T; Balosso J J Chir (Paris); 1999 Dec; 136(6):309-17. PubMed ID: 10675820 [TBL] [Abstract][Full Text] [Related]
26. Review of adjuvant radiochemotherapy for resected pancreatic cancer and results from Mayo Clinic for the 5th JUCTS symposium. Miller RC; Iott MJ; Corsini MM Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):364-8. PubMed ID: 19735864 [TBL] [Abstract][Full Text] [Related]
27. Adjuvant intra-arterial chemotherapy and radiotherapy versus surgery alone in resectable pancreatic and periampullary cancer: a prospective randomized controlled trial. Morak MJ; van der Gaast A; Incrocci L; van Dekken H; Hermans JJ; Jeekel J; Hop WC; Kazemier G; van Eijck CH Ann Surg; 2008 Dec; 248(6):1031-41. PubMed ID: 19092348 [TBL] [Abstract][Full Text] [Related]
28. Time to the initiation of adjuvant chemotherapy does not impact survival in patients with resected pancreatic cancer. Mirkin KA; Greenleaf EK; Hollenbeak CS; Wong J Cancer; 2016 Oct; 122(19):2979-87. PubMed ID: 27328270 [TBL] [Abstract][Full Text] [Related]
29. Treatment of pancreatic cancer: challenge of the facts. Beger HG; Rau B; Gansauge F; Poch B; Link KH World J Surg; 2003 Oct; 27(10):1075-84. PubMed ID: 12925907 [TBL] [Abstract][Full Text] [Related]
34. The cost-effectiveness of neoadjuvant chemoradiation is superior to a surgery-first approach in the treatment of pancreatic head adenocarcinoma. Abbott DE; Tzeng CW; Merkow RP; Cantor SB; Chang GJ; Katz MH; Bentrem DJ; Bilimoria KY; Crane CH; Varadhachary GR; Abbruzzese JL; Wolff RA; Lee JE; Evans DB; Fleming JB Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S500-8. PubMed ID: 23397153 [TBL] [Abstract][Full Text] [Related]
35. Neoadjuvant therapy versus upfront surgery for resected pancreatic adenocarcinoma: A nationwide propensity score matched analysis. de Geus SW; Eskander MF; Bliss LA; Kasumova GG; Ng SC; Callery MP; Tseng JF Surgery; 2017 Mar; 161(3):592-601. PubMed ID: 28341441 [TBL] [Abstract][Full Text] [Related]
36. Neoadjuvant chemoradiation for adenocarcinoma of the pancreas. Breslin TM; Janjan NA; Lee JE; Pisters PW; Wolff RA; Abbruzzese JL; Evans DB Front Biosci; 1998 Nov; 3():E193-203. PubMed ID: 9792895 [TBL] [Abstract][Full Text] [Related]
37. Regional targeting chemoimmunotherapy in patients undergoing pancreatic resection in an advanced stage of their disease: a prospective randomized study. Lygidakis NJ; Sgourakis G; Georgia D; Vlachos L; Raptis S Ann Surg; 2002 Dec; 236(6):806-13. PubMed ID: 12454519 [TBL] [Abstract][Full Text] [Related]
38. A phase II single institutional experience with preoperative radiochemotherapy in pancreatic adenocarcinoma. Moutardier V; Giovannini M; Lelong B; Monges G; Bardou VJ; Magnin V; Charaffe-Jauffret E; Houvenaeghel G; Delpero JR Eur J Surg Oncol; 2002 Aug; 28(5):531-9. PubMed ID: 12217307 [TBL] [Abstract][Full Text] [Related]
39. Neoadjuvant therapy for resectable pancreatic cancer. Raut CP; Evans DB; Crane CH; Pisters PW; Wolff RA Surg Oncol Clin N Am; 2004 Oct; 13(4):639-61, ix. PubMed ID: 15350939 [TBL] [Abstract][Full Text] [Related]
40. Neoadjuvant treatment for resectable pancreatic cancer: time for phase III testing? Reni M World J Gastroenterol; 2010 Oct; 16(39):4883-7. PubMed ID: 20954273 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]